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Received February 8, 2011; accepted July 11, 2011AbstractChoroidal metastasis is the most common type of intraocular tumor in adults, and in females the most common primary site is the breast. We
report a case of unilateral choroidal metastasis with exudative retinal detachment as the initial presentation of recurrent breast cancer, and
subsequent ophthalmic metastasis following diagnostic vitrectomy. A 49-year-old woman with a 7-year-history of well-treated bilateral breast
cancer had been suffering from blurred vision in the left eye for 1 week. Ocular examination was normal except for superotemporal retinal
detachment in the left eye. Neither retinal break nor choroidal mass was seen. The patient received scleral buckling and pneumatic retinopexy
without significant improvement. Fluorescein angiography revealed a suspected choroidal metastasis in the left eye, but ocular ultrasonography
did not show a visible choroidal mass. Two consecutive diagnostic vitrectomies with cytology could not confirm malignancy. A systemic workup
was also negative. Six months later, two tumor masses were noted over two of the sclerotomy wounds of the left eye. Pathology showed
adenocarcinoma compatible with invasive ductal carcinoma of the breast. Ocular metastasis may present as infiltrative choroidal lesions with
exudative retinal detachment without a visible mass. Invasive procedures, such as fine-needle aspiration biopsy and diagnostic vitrectomy, may
risk tumor seeding.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Choroidal metastasis is the most common type of intraoc-
ular tumor in adults. The most common primary tumors that
metastasize to the choroid are breast cancer in females and
lung cancer in males. Most intraocular tumors can be diag-
nosed by noninvasive techniques,1 but those with atypical
features may need additional cytological or histological
confirmation. Diagnostic vitrectomy and fine-needle aspiration
are common methods to evaluate patients with indeterminate
posterior intraocular tumors.2 However, these invasive* Corresponding author. Dr. Tsung-Tien Wu, Department of Ophthalmology,
Kaohsiung Veterans General Hospital, 386, Ta-Chung 1st Road, Kaohsiung
813, Taiwan, ROC.
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http://dx.doi.org/10.1016/j.jcma.2012.06.023techniques may increase the risk of extraocular tumor spread
and orbital seeding.3,4 We present a case of choroidal metas-
tasis from recurrent breast cancer with subsequent tumor
seeding over sclerotomy wounds following pars plana
vitrectomy.
2. Case report
A 49-year-old female had undergone mastectomy and
chemotherapy for bilateral breast cancer approximately 7
years previously. No evidence of recurrence was noted during
regular follow-up. The patient was referred because of blurred
vision in the left eye of 1 week’s duration. Vision was 6/6 in
the right eye and 6/12 in the left. Intraocular pressure was
14 mmHg in the right eye and 10 mmHg in the left. Ocular
examination was normal except for bullous retinal detachment
noted at the periphery of the superotemporal quadrant in thehinese Medical Association. All rights reserved.
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mass was detected under indirect ophthalmoscopy. There was
no obvious shifting of subretinal fluid upon changing posture.
To address this case of diagnostic uncertainty, scleral
buckling and pneumatic retinopexy were performed initially.
However, subretinal fluid persisted after the operation
(Fig. 1B). We arranged for fluorescein angiography for eval-
uation, and choroidal metastasis was suspected in the left eye
(Fig. 1C and 1D). Ocular ultrasonography showed no visible
choroidal mass or abnormal acoustic reflectivity. A systemic
survey provided no more clinical findings or distant dissemi-
nation, and a gallium-67 scintigraphy scan did not reveal any
malignancy.Fig. 1. Fundus photography and fluorescein angiography. (A) A bullous retinal detac
without a shifting pattern of the subretinal fluid. (B) Persistent subretinal fluid
angiography showed hypofluorescence over the lesion during the early phase. (D
subretinal and choroidal levels, with late leakage into the subretinal space, sugg
choroidal patches with flat, ill-defined margins were scattered diffusely over the pIn the following 2 months, two consecutive pars plana
vitrectomies were performed on the patient to establish
a diagnosis and to reattach the retina. Retinotomy was created
after thorough vitrectomy, and subretinal fluid was aspirated
through the retinotomy with a 25-gauge needle. An endo-
diode laser was applied at the margin of the retinotomy.
Both the vitreous specimen and subretinal fluid were sent for
cytological examination, but no malignant cells were found.
Rapidly, numerous whitish choroidal patches with flat, ill-
defined margins scattered diffusely over the posterior pole
and mid-periphery in the left eye (Fig. 1E). The patient was
advised to receive evaluation and treatment at the oncology
department.hment was seen at the periphery of the superotemporal quadrant in the left eye
was noted after scleral buckling and pneumatic retinopexy. (C) Fluorescein
) During the venous phase, multiple hyperfluorescent spots appeared at the
estive of choroidal metastasis. (E) About 2 months later, numerous whitish
osterior pole and mid-periphery.
Fig. 2. Clinical appearance and microscopic examination of the tumor. (A) A tumor mass measuring 0.4 cm  0.3 cm  0.3 cm was noted over the sclerotomy
wound in the left eye. (B) A cross-section of the tumor mass (H&E stain, 40) showed nests and cords of neoplastic cells with stromal invasion. (C) The
morphology was compatible with metastasis from invasive ductal carcinoma of the breast (H&E stain, 400).
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were noted over two of the three sclerotomy wounds in the left
eye (Fig. 2A). Excisional biopsy was performed with cryo-
therapy, and pathology showed adenocarcinoma consistent
with an origin of invasive ductal carcinoma of the breast
(Fig. 2B and 2C).
3. Discussion
Uveal metastasis accounts for a considerable number of
intraocular tumors in adults, with breast and lung cancer being
the leading primary sites in women and men, respectively.5 In
a study by Shields et al, the uveal metastasis came from
a primary cancer of the breast in 47% of cases, the lung in
21%, and the gastrointestinal tract in 4%.5Tumor cells may
metastasize to the eye via hematogenous dissemination, with
the posterior choroid being the most common site of intraoc-
ular metastases due to its rich vascular supply.6e8
Patients with choroidal metastasis may be asymptomatic or
may experience photopsia and, rarely, pain. The most common
sites of involvement are the superior and temporal quadrants
of the postequatorial region.6 Fully 91% of patients with
choroidal metastasis have posterior pole involvement, and they
may experience blurred vision and metamorphopsia.6,9 Only
6% of patients have peripheral retinal involvement.9 Meta-
static tumors from breast cancer may be solitary or multifocal,
unilateral or bilateral, and may have diverse findings on
dilated fundus examination.9 In retrospective reviews by
Kreusel et al and Demirci et al, most eyes with choroidal
metastasis from breast cancer showed flat, yellow-white
lesions with diffuse borders and a mean tumor thickness of
2 mm (range 0.3e15 mm).9,10 The lesions had variable
degrees of pigmentation: 55% were mottled, 40% showed no
pigmentation, and 5% were densely pigmented.9 Exudative
retinal detachment may be present with shifting subretinal
fluid, but retinal hemorrhage and exudates are rare.10
When attempting to make a diagnosis, fine-needle aspira-
tion biopsy and diagnostic vitrectomy may help detect
malignancy, speeding the application of specific and appro-
priate treatment.2,4 However, these procedures still have
limitations. Fine-needle aspiration biopsy is unreliable in
lesions thinner than 2 mm, and inadequate samples or
sampling errors may lead to false-negative results.4 Severe
complications may occur, such as spreading of the tumor,hemorrhage, retinal detachment, cataract and endophthalmitis
related to the procedure.2e4,11 The faint risk of needle track
seeding is more likely with trans-scleral fine-needle biopsies
compared with the transvitreal approach.11 Although the risk
of tumor cell dissemination is generally low in fine-needle
biopsy, local epibulbar seeding at the scleral pars plana
puncture site was once reported in a case of posterior temporal
melanoma after a transvitreal biopsy.12
Our patient had a unilateral, flat amelanotic lesion that
presented initially at the periphery of the superotemporal
quadrant with a bullous retinal detachment; however, neither
obvious shifting patterns of subretinal fluid nor a tumor mass
were noted at that time. Despite systemic evaluation, two
consecutive diagnostic vitrectomies and cytological examina-
tion of the subretinal fluid and vitreous samples, we could not
confirm the presumed diagnosis of metastasis. The lesion
rapidly progressed to multifocal infiltrative subretinal foci
with a yellow-white color and an ill-defined margin diffused
over the posterior pole. Although we did not obtain sufficient
material for cytological confirmation of malignancy,
a subclinical number of scant tumor cells were implanted at
the sclerotomy puncture site. Probes introduced through the
sclerotomy during vitrectomy may have increased the risk of
seeding in this case.
Choroidal metastasis from breast cancer may occur many
years after operation, with most cases diagnosed 20e40
months postoperatively.13 Usually, ocular metastasis is
preceded by involvement of the lungs or other organs.13
Nonetheless, after a relatively prolonged 7 years of remis-
sion, our patient developed ocular metastasis as the initial
presentation of a systemic recurrence of her breast cancer. This
case indicates that a careful systemic survey and history-taking
are mandatory for the diagnosis of unusual presentations.
Invasive procedures, such as fine-needle aspiration biopsy and
diagnostic vitrectomy, may aid rapid diagnosis, but clinicians
should be cautious of the potential risk of extraocular spread
of tumor cells.References
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